Reference answer · 340b-program · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · 340b-program

How does HRSA determine 340B ceiling prices and covered outpatient drug status?

HRSA defines a 'covered outpatient drug' by referencing section 1927(k) of the Social Security Act, using Medicaid’s rebate definitions that exclude inpatient bundles and non‑FDA‑approved supplies. Ceiling prices are calculated from the Average Manufacturer Price minus the Medicaid Unit Rebate Amount, with HRSA posting quarterly updates in its secure portal.

Related questions.

Q&A librarySourced · reviewed quarterly
340b-programHow is HRSA changing 340B drug diversion oversight for specialty pharmacies in 2026?340b-programHow does HRSA enforce 340B re-registration after hospital mergers in 2026?340b-programHow will HRSA verify 340B child site eligibility during 2026 audits?340b-programHow can hospitals maintain 340B eligibility for offsite clinics in 2026?340b-programHow will HRSA verify 340B patient definition compliance across multi-site systems in 2026?340b-programHow is HRSA enforcing 340B duplicate discount rules for Medicaid MCO claims in 2026?
Browse all canonical questions →